[1]
Shahzad, K. et al. 2020. Role of intravitreal ranibizumab for rapid recovery of central serous chorioretinopathy. Journal of Fatima Jinnah Medical University. 14, 2 (Jul. 2020), 78–82. DOI:https://doi.org/10.37018/ykjf3651.